Proteostasis is differentially modulated by inhibition of translation initiation or elongation

  1. Khalyd J Clay
  2. Yongzhi Yang
  3. Christina Clark
  4. Michael Petrascheck  Is a corresponding author
  1. Scripps Research Institute, United States

Abstract

Recent work has revealed an increasingly important role for mRNA translation in maintaining proteostasis. Here, we use chemical inhibitors targeting discreet steps of translation to compare how lowering the concentration of all or only translation initiation-dependent proteins rescues Caenorhabditis elegans from proteotoxic stress. We systematically challenge proteostasis and show that pharmacologically inhibiting translation initiation or elongation elicits a distinct protective profile. Inhibiting elongation protects from heat and proteasome dysfunction independently from HSF-1 but does not protect from age-associated protein aggregation. Conversely, inhibition of initiation protects from heat and age-associated protein aggregation and increases lifespan, dependent on hsf-1, but does not protect from proteotoxicity caused by proteasome dysfunction. Surprisingly, we find that the ability of the translation initiation machinery to control the concentration of newly synthesized proteins depends on HSF-1. Inhibition of translation initiation in wild-type animals reduces the concentration of newly synthesized proteins but increases it in hsf-1 mutants. Our findings suggest that the HSF-1 pathway is not only a downstream target of translation but also directly cooperates with the translation initiation machinery to control the concentration of newly synthesized proteins to restore proteostasis.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.

Article and author information

Author details

  1. Khalyd J Clay

    Department of Molecular Medicine, Scripps Research Institute, La Jolla, United States
    Competing interests
    Khalyd J Clay, is a scientific founder and advisor to Cyclone Therapeutics, Inc., a biotech company developing therapeutics targeting translation..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1381-5295
  2. Yongzhi Yang

    Department of Molecular Medicine, Scripps Research Institute, La Jolla, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9713-0009
  3. Christina Clark

    Department of Molecular Medicine, Scripps Research Institute, La Jolla, United States
    Competing interests
    No competing interests declared.
  4. Michael Petrascheck

    Department of Molecular Medicine, Scripps Research Institute, La Jolla, United States
    For correspondence
    pscheck@scripps.edu
    Competing interests
    Michael Petrascheck, is a scientific founder and advisor to Cyclone Therapeutics, Inc., a biotech company developing therapeutics targeting translation..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1010-145X

Funding

National Institutes of Health (R21NS107951)

  • Michael Petrascheck

National Institute on Aging (R01AG067331)

  • Michael Petrascheck

The Glenn Foundation

  • Michael Petrascheck

Dorris Neuroscience Scholar Fellowship

  • Khalyd J Clay

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Clay et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,599
    views
  • 285
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Khalyd J Clay
  2. Yongzhi Yang
  3. Christina Clark
  4. Michael Petrascheck
(2023)
Proteostasis is differentially modulated by inhibition of translation initiation or elongation
eLife 12:e76465.
https://doi.org/10.7554/eLife.76465

Share this article

https://doi.org/10.7554/eLife.76465

Further reading

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.